Trials / Unknown
UnknownNCT00132184
Vitamin D Treatment for Crohn´s Disease
Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 110 (planned)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine whether vitamin D treatment is effective in Crohn's disease.
Detailed description
Crohns Disease is an inflammatory disease of primarily the small intestine and colon. In recent years scientists have hypothesized that low blood vitamin-D levels play a role in the development of autoimmune diseases, including Crohns disease. The purpose of this study is to examine whether vitamin-D is effective in keeping remission in inactive Crohns Disease (double blind placebo controlled trial). The patients who have active disease in the placebo group (reach primary endpoint), will in an open setting receive a higher single dose vitamin-D and the effect will be measured within 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D |
Timeline
- Start date
- 2005-09-01
- Completion
- 2008-02-01
- First posted
- 2005-08-19
- Last updated
- 2007-04-13
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00132184. Inclusion in this directory is not an endorsement.